STK3 Suppresses Ovarian Cancer Progression by Activating NF-κB Signaling to Recruit CD8+ T-Cells
Serine/threonine protein kinase-3 (STK3) is a critical molecule of the Hippo pathway but little is known about its biological functions in the ovarian cancer development. We demonstrated the roles of STK3 in ovarian cancer. Existing databases were used to study the expression profile of STK3. STK3 w...
Main Authors: | Xiangyu Wang, Fengmian Wang, Zhi-Gang Zhang, Xiao-Mei Yang, Rong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/7263602 |
Similar Items
-
Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis
by: Chenglin Han, et al.
Published: (2021-01-01) -
NF-κB Signaling in Ovarian Cancer
by: Brittney S. Harrington, et al.
Published: (2019-08-01) -
NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.
by: Masaya Uno, et al.
Published: (2014-01-01) -
Reseach progress of NF-κB in the field of ophthalmology
by: Hong Lou, et al.
Published: (2017-02-01) -
LINC00494 Promotes Ovarian Cancer Development and Progression by Modulating NFκB1 and FBXO32
by: Yang Shu, et al.
Published: (2021-01-01)